Showing results (611-620 of 653) with videos related to

Sort By:
Pageof 66
Clinical Chemistry|September 17, 2013
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities studyVijay Nambi, Xiaoxi Liu, Lloyd E Chambless, et al.
American Heart Journal|March 23, 2022
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular diseaseSebhat Erqou, Alexa Papaila, Christopher Halladay, et al.
American Journal of Preventive Cardiology|June 19, 2025
Coronary inflammation and atherosclerosis by CCTA in young adults (aged 18-45)Annalisa Filtz, Daniel Lorenzatti, Henry A Dwaah, et al.
Plos One|December 21, 2018
Making prescriptions "talk" to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study)Ayeesha Kamran Kamal, Wardah Khalid, Abdul Muqeet, et al.
The American Journal of Cardiology|February 4, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)Aliza Hussain, Olive Tang, Caroline Sun, et al.
Vascular Medicine (London, England)|September 6, 2024
Predictors of incident stroke among individuals without coronary artery calcification: A pooled cohort analysis from the Multi-Ethnic Study of Atherosclerosis, Jackson Heart Study, and Framingham Heart StudyAliza Hussain, Michelle C Johansen, Michael J Blaha, et al.
American Journal of Preventive Cardiology|June 6, 2025
South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population - An American society for preventive cardiology clinical practice statementAnand Rohatgi, Sonia S Anand, Meghana Gadgil, et al.
European Heart Journal. Cardiovascular Imaging|April 5, 2024
Interaction between risk factors, coronary calcium, and CCTA plaque characteristics in patients aged 18-45 yearsDaniel Lorenzatti, Pamela Piña, Dou Huang, et al.
Journal of the American College of Cardiology|June 9, 2026
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of CardiologySadiya S Khan, Chiadi E Ndumele, Nicole Bhave, et al.
JACC. Heart Failure|May 16, 2024
Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort AnalysisAmbarish Pandey, Kershaw V Patel, Matthew W Segar, et al.
Pageof 66